Table 6.
Caspase | Cells (%)
|
|||||
---|---|---|---|---|---|---|
12 h
|
24 h
|
48 h
|
||||
Control | Treated | Control | Treated | Control | Treated | |
Caspase-3 | 0.064±0.030 | 0.173±0.01* | 0.091±0.051 | 0.29±0.007* | 0.11±0.0032 | 0.41±0.006* |
Caspase-9 | 0.077±0.071 | 0.176±0.03* | 0.082±0.001 | 0.25±0.005* | 0.10±0.002 | 0.33±0.0035* |
Notes: Values are expressed as mean ± SD of triplicate experiments. Data has been analyzed using one-way ANOVA with Tukey’s test for post hoc comparison.
For each treatment period is significantly (P>0.05) different from control.
Abbreviations: ANOVA, analysis of variance; MOLT-4, human leukemia cell line; NPs, nanoparticles; Pd, palladium; W.tea, white tea.